Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Molecular Imaging in Intracranial Metastatic Disease.

Created on 12 Nov 2026

Authors

Gokce Belge Bilgin, Cem Bilgin, Ephraim E Parent, Derek R Johnson

Published in

Neuroimaging clinics of North America. Volume 37. Issue 1. Pages 155-168. Epub Sep 30, 2026.

Abstract

Neuroimaging plays a central role in the management of intracranial metastatic disease (IMD), providing the foundation for diagnosis, treatment planning, and posttherapy surveillance. MR imaging has limitations in certain clinical scenarios, particularly in differentiating actual tumor progression from treatment-related changes such as radiation necrosis. Growing evidence supports the complementary role of molecular imaging, particularly amino acid PET, in providing metabolic insights that can enhance diagnostic accuracy in these complex situations in the setting of IMD. This comprehensive article examines the expanding role of molecular imaging in IMD and highlights the emerging clinical insights PET may offer to improve patient care.

PMID:
43014977
Bibliographic data and abstract were imported from PubMed on 12 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement